This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

FIB - 4 index in NAFLD

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The FIB-4 index incorporates routinely available clinical data including age, AST, platelet count (PLT), and ALT level according to Sterling’s formula as follows:

[Age (years)×AST (IU/L)]/[PLT (10 9/L)×ALT 1/2 (IU/L)]

 

online FIB-4 calculator - click here

  • the scoring system creates a score - <1.45 has a negative predictive value of over 90% for advanced liver fibrosis of multiple aetiologies (1)(2)
  • a score of >3.25 has a positive predictive value of 65% for advanced fibrosis with a specificity of 97%
  • it has been suggested (3):
    • A FIB-4 index<1.45 in a context of fatty liver disease excludes clinically significant hepatic fibrosis
    • additional explorations are mandatory to excluded hepatic fibrosis for a a FIB-4 index>1.45 in a context of fatty liver disease
    • a complete hepatological workup is mandatory for a FIB-4 index>3.25 in a context of fatty liver disease

Reference:

  • Sterling RK, Lissen E, Clumeck N, et. al. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co-infection. Hepatology 2006;43:1317-1325
  • McPherson S, Stewart SF, Henderson E et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010;59:1265–9 doi:10.1136/gut.2010.216077
  • Mallett V et al.FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients. Presse Med 2019 Dec;48(12):1484-1488.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.